Related Experiment Videos
Inhibition of tumor cell proliferation by dimerized ribonuclease
Abstract:
A cross-linked dimer of pancreatic ribonuclease A (ribonucleate 3'-pyrimidino-olitonucleotidohydrolase, EC 3.1.4.22), at a 10 mg/liter concentration, blocks proliferation of tumor cells. The protein retains this ability after inactivation by iodoacetate. The cytostatic effect of ribonuclease preparations on various cell lines correlates well with their rate of uptake: for example, monomeric ribonuclease A is much less effective and is taken up into the cells 10 t0 15 times more slowly. Cell fractionation studies on hepatoma cells indicate accumulation of the dimer in the lysosomal system. Ribonuclease dimer induces a labilization of the lysosomes when added to cell homogenates, raising the possibility that its antitumoral effect may be mediated by endocytosis and lysosomes.
Insights
A pancreatic ribonuclease A dimer effectively blocks tumor cell proliferation, even after inactivation. Its anti-tumor effects are linked to cellular uptake and lysosomal activity, suggesting a novel therapeutic mechanism.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Pancreatic ribonuclease A (RNase A) is an enzyme involved in RNA metabolism.
- Tumor cell proliferation is a hallmark of cancer, and targeting this process is a key therapeutic strategy.
Purpose of the Study:
- To investigate the anti-proliferative effects of a cross-linked dimer of pancreatic ribonuclease A on tumor cells.
- To elucidate the mechanism of action, including cellular uptake and the role of lysosomes.
Main Methods:
- Preparation and characterization of pancreatic ribonuclease A dimer.
- Treatment of various tumor cell lines with the ribonuclease dimer.
- Assessment of cell proliferation and protein uptake.
- Cell fractionation studies and lysosomal labilization assays.
Main Results:
- The pancreatic ribonuclease A dimer (10 mg/liter) inhibited tumor cell proliferation.
- The cytostatic effect correlated with cellular uptake; monomeric RNase A was less effective and taken up slower.
- Inactivated ribonuclease dimer retained its anti-proliferative activity.
- Hepatoma cell studies showed dimer accumulation in lysosomes, which were labilized upon dimer addition.
Conclusions:
- The cross-linked pancreatic ribonuclease A dimer exhibits significant anti-tumor activity.
- Cellular uptake and lysosomal mechanisms, potentially involving endocytosis, may mediate the dimer's cytostatic effects.
- Further research into ribonuclease dimers as anti-cancer agents is warranted.